Indexed keywords
CYCLOSPORIN;
DESMOPRESSIN;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RITUXIMAB;
SODIUM CHLORIDE;
TRANEXAMIC ACID;
ABSENCE OF SIDE EFFECTS;
BLEEDING;
CASE REPORT;
DISEASE SEVERITY;
DRUG MECHANISM;
HIGH RISK PATIENT;
HUMAN;
MALE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
REFRACTORY THROMBOCYTOPENIA;
REVIEW;
SPLENECTOMY;
SURGICAL TECHNIQUE;
SYMPTOMATOLOGY;
THERAPY RESISTANCE;
THROMBIN TIME;
THROMBOCYTE ACTIVATION;
THROMBOCYTE TRANSFUSION;
TREATMENT INDICATION;
CHILD, PRESCHOOL;
CHRONIC DISEASE;
FACTOR VIIA;
HUMANS;
INFANT;
MALE;
PLATELET COUNT;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
RECOMBINANT PROTEINS;
SEVERITY OF ILLNESS INDEX;
SPLENECTOMY;
TREATMENT OUTCOME;
1
0344304491
Childhood chronic immune thrombocytopenic purpura: Unresolved issues
Blanchette VS, Price V. Childhood chronic immune thrombocytopenic purpura: Unresolved issues. J Pediatr Hematol Oncol 2003; 25:28-33.
(2003)
J Pediatr Hematol Oncol , vol.25
, pp. 28-33
Blanchette, V.S.1
Price, V.2
2
0033852696
Approach to the investigation and management of immune thrombocytopenic purpura in children
Blanchette V, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 2000;37:299-314.
(2000)
Semin Hematol , vol.37
, pp. 299-314
Blanchette, V.1
Carcao, M.2
3
0033967563
Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura
Bussel JB. Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 2000;37:1-5.
(2000)
Semin Hematol , vol.37
, pp. 1-5
Bussel, J.B.1
4
0032944743
Prevention and management of overwhelming postsplenectomy infection-an update
Brigden ML, Pattullo AI. Prevention and management of overwhelming postsplenectomy infection-an update. Crit Care Med 1999;27:836-842.
(1999)
Crit Care Med , vol.27
, pp. 836-842
Brigden, M.L.1
Pattullo, A.I.2
5
0036267709
Technical standardization of laparoscopic splenectomy. Experience with 105 cases
Corcione F, Esposito C, Cuccurullo D, et al. Technical standardization of laparoscopic splenectomy. Experience with 105 cases. Surg Endosc 2002;16:972-974.
(2002)
Surg Endosc , vol.16
, pp. 972-974
Corcione, F.1
Esposito, C.2
Cuccurullo, D.3
6
3242709784
Recombinat activated factor VII for non-hemophiliac bleeding patients
Uhlmann EJ, Eby CS. Recombinat activated factor VII for non-hemophiliac bleeding patients. Curr Opin Hematol 2004;11:198-204.
(2004)
Curr Opin Hematol , vol.11
, pp. 198-204
Uhlmann, E.J.1
Eby, C.S.2
7
0033764370
The factor VII-platelet interplay: Effectiveness of recombinant factor Vila in the treatment of bleeding in severe thrombocytopatia
Monroe DM, Hoffman M, Allen GA, et al. The factor VII-platelet interplay: Effectiveness of recombinant factor Vila in the treatment of bleeding in severe thrombocytopatia. Semin Thromb Haemost 2000;26:373-377.
(2000)
Semin Thromb Haemost , vol.26
, pp. 373-377
Monroe, D.M.1
Hoffman, M.2
Allen, G.A.3
8
0037837277
Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits
Tranholm M, Rojkjaer R, Pyke C, et al. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits. Thromb Res 2003;109:217-223.
(2003)
Thromb Res , vol.109
, pp. 217-223
Tranholm, M.1
Rojkjaer, R.2
Pyke, C.3
9
0036033535
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: Is there a role for recombinant activated factor VII?
Kessler C. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: Is there a role for recombinant activated factor VII? Intensive Care Med 2002;28:228-234.
(2002)
Intensive Care Med , vol.28
, pp. 228-234
Kessler, C.1
11
0030729382
Desmopressin - A haemostatic drug: State-of-the-art review
Lethagen S. Desmopressin-a haemostatic drug: State-of-the-art review. Europ J Anaest 1997;14:1-9.
(1997)
Europ J Anaest , vol.14
, pp. 1-9
Lethagen, S.1
